pRb2 p130 Antibody, Rabbit, Polyclonal

Artikelnummer: ROC-600-401-B11
Artikelname: pRb2 p130 Antibody, Rabbit, Polyclonal
Artikelnummer: ROC-600-401-B11
Hersteller Artikelnummer: 600-401-B11
Alternativnummer: ROC-600-401-B11
Hersteller: Rockland Immunochemicals
Wirt: Rabbit
Kategorie: Antikörper
Applikation: ELISA, WB
Spezies Reaktivität: Human
Immunogen: This affinity purified antibody was prepared by repeated immunizations with a synthetic peptide corresponding to the Spa310 sequence of pRb2/p130 protein. A residue of cysteine was added to facilitate coupling.
Konjugation: Unconjugated
Alternative Synonym: rabbit anti-pRb2/p130 antibody, rabbit anti-pRb2 antibody, rabbit anti-p130 antibody, rabbit anti-Spa310 antibody, 130 kDa retinoblastoma associated protein antibody, RBR-2 antibody, RBL2 antibody, RB2 antibody, Retinoblastoma like 2 antibody, Retinoblastoma like protein 2 antibody, Retinoblastoma Related Gene antibody
Klonalität: Polyclonal
Konzentration: 1.39 mg/mL by UV absorbance at 280 nm
NCBI: 5934
UniProt: Q08999
Puffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Formulierung: Liquid (sterile filtered)
Target-Kategorie: Human
Antibody Type: Primary Antibody
Application Verdünnung: ELISA: 1:75,000 - 1:100,000, IP: 1:100, WB: 1:500 - 1:5,000
Anwendungsbeschreibung: This affinity purified antibody is tested for ELISA and western blotting. Specific conditions for reactivity should be optimized by the end user. Expect a band approximately 130 kDa in size corresponding to pRb2/p130, and a band approximately 4.2kDa in s
Western blot using Rocklands affinity purified anti-Spa310 antibody shows detection of endogenous pRb2/p130 protein in whole LNCaP cell extracts. The band at ~130 kDa, indicated by the arrowhead, corresponds to the expected molecular weight of pRb2/p130. The membrane was blocked overnight with a milk buffer at 4 C. Primary antibody was diluted 1:500 and reacted with the membrane overnight at 4 C. ECL was used for detection. Personal communication, Ang Sun, Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, PA.